» Articles » PMID: 29436563

The Rising Trend in Papillary Thyroid Carcinoma. True Increase or over Diagnosis?

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2018 Feb 14
PMID 29436563
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the changes in parameters of thyroid carcinoma, particularly papillary type, in the era of widespread use of sensitive diagnostic methods. We aim to investigate whether the increased frequency of thyroid cancer is true or resulted from over diagnosis. Methods: We conducted a retrospective study of 313 cases of thyroid carcinoma diagnosed at Jordan University Hospital and King Hussein Cancer Center from 2007-2015. Papillary carcinoma accounted for 290 (92.7%) of all cases. Cases were sub classified according to demographic features, histological type, size, stage, and other variables. For comparison of data, cases were subdivided into 2 study periods: Group I included patients diagnosed in the period 2007-2010, and Group II in the period 2011-2015. Results: The frequency of thyroid carcinoma has increased across the study period. Papillary carcinoma was the major type accounting for this increase. Papillary micro carcinomas ≤1cm accounted for 34.8% of cases of PTC. Most cases (52.4%) of papillary thyroid carcinoma (PTC) were localized stage tumors. Group II of the study witnessed a more than doubled number of cases of PTC compared to group I, with increased frequency of tumors of all sizes as well as tumors of both localized and regional stages. Conclusions: Our observed trend cannot be totally explained by over diagnosis and increased diagnostic scrutiny. This increase could be of true nature and cannot be explained by single cause.

Citing Articles

Vitamin C in the Management of Thyroid Cancer: A Highway to New Treatment?.

Gorini F, Tonacci A Antioxidants (Basel). 2024; 13(10).

PMID: 39456495 PMC: 11505632. DOI: 10.3390/antiox13101242.


Research on the expression of Mir-218-2 in the serum of patients with papillary thyroid cancer and its clinical significance.

He H, Hao D, Tian L, Zhu C, Guo L, Zhang K Eur J Transl Myol. 2024; 34(3).

PMID: 39221591 PMC: 11487670. DOI: 10.4081/ejtm.2024.12678.


Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus.

Zheng D, Yang J, Qian J, Jin L, Huang G Cancer Manag Res. 2022; 14:3493-3505.

PMID: 36573167 PMC: 9789701. DOI: 10.2147/CMAR.S366270.


Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.

Zhu J, Huang R, Yu P, Ren H, Su X Int J Endocrinol. 2022; 2022:3534783.

PMID: 35265124 PMC: 8901297. DOI: 10.1155/2022/3534783.


Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis.

Alqahtani W, Almufareh N, Mostafa Domiaty D, Albasher G, Alduwish M, Alkhalaf H AIMS Public Health. 2020; 7(3):679-696.

PMID: 32968686 PMC: 7505779. DOI: 10.3934/publichealth.2020053.


References
1.
Pathak K, Leslie W, Klonisch T, Nason R . The changing face of thyroid cancer in a population-based cohort. Cancer Med. 2013; 2(4):537-44. PMC: 3799288. DOI: 10.1002/cam4.103. View

2.
Hussain F, Iqbal S, Mehmood A, Bazarbashi S, Elhassan T, Chaudhri N . Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013; 6(2):58-64. DOI: 10.1016/j.hemonc.2013.05.004. View

3.
Davies L, Welch H . Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140(4):317-22. DOI: 10.1001/jamaoto.2014.1. View

4.
Amphlett B, Lawson Z, Abdulrahman Jr G, White C, Bailey R, Premawardhana L . Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010. Thyroid. 2013; 23(11):1470-8. DOI: 10.1089/thy.2012.0573. View

5.
Moon H, Lee H, Kim E, Ko S, Seo J, Park W . Thyroid nodules ≤ 5 mm on ultrasonography: are they "leave me alone" lesions?. Endocrine. 2015; 49(3):735-44. DOI: 10.1007/s12020-015-0526-9. View